P
Panagiotis Karyofillis
Publications - 22
Citations - 539
Panagiotis Karyofillis is an academic researcher. The author has contributed to research in topics: Stent & Coronary artery disease. The author has an hindex of 10, co-authored 22 publications receiving 498 citations.
Papers
More filters
Journal ArticleDOI
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.
Emmanouil S. Brilakis,Christopher Lichtenwalter,Christopher Lichtenwalter,James A. de Lemos,Michele Roesle,Owen Obel,Donald Haagen,Bilal Saeed,Chiranjeevi Gadiparthi,Chiranjeevi Gadiparthi,Joe K. Bissett,Rajesh Sachdeva,Vassilios V. Voudris,Panagiotis Karyofillis,Biswajit Kar,James D. Rossen,Panayotis Fasseas,Peter B. Berger,Subhash Banerjee +18 more
TL;DR: In saphenous vein graft (SVG) lesions, PES are associated with lower rates of angiographic restenosis and target vessel failure than BMS.
Journal ArticleDOI
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial
Emmanouil S. Brilakis,Christopher Lichtenwalter,Christopher Lichtenwalter,Abdul Rahman R Abdel-Karim,Abdul Rahman R Abdel-Karim,James A. de Lemos,Owen Obel,Owen Obel,Tayo Addo,Michele Roesle,Donald Haagen,Bavana V. Rangan,Bilal Saeed,Joe K. Bissett,Rajesh Sachdeva,Vassilios V. Voudris,Panagiotis Karyofillis,Biswajit Kar,James D. Rossen,Panayotis Fasseas,Peter B. Berger,Subhash Banerjee +21 more
TL;DR: During long-term follow-up, use of PES was associated with significantly better clinical outcomes than BMS in SVG lesions, compared with patients randomized to BMS.
Journal ArticleDOI
Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After Stenting: Insights From the SOS (Stenting Of Saphenous Vein Grafts) Trial
Christopher Lichtenwalter,Christopher Lichtenwalter,James A. de Lemos,James A. de Lemos,Michele Roesle,Owen Obel,Owen Obel,Elizabeth M. Holper,Donald Haagen,Bilal Saeed,Jose Miguel Iturbe,Jose Miguel Iturbe,Kendrick A. Shunk,Joe K. Bissett,Rajesh Sachdeva,Vassilios V. Voudris,Panagiotis Karyofillis,Biswajit Kar,James D. Rossen,Panayotis Fasseas,Peter B. Berger,Subhash Banerjee,Subhash Banerjee,Emmanouil S. Brilakis,Emmanouil S. Brilakis +24 more
TL;DR: Compared with BMS, PES reduce SVG failure, and SVG failure after stenting often presents as acute myocardial infarction and with SVG occlusion.
Journal ArticleDOI
Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience.
Anna Kostopoulou,Panagiotis Karyofillis,Efthimios G. Livanis,Sofia Thomopoulou,Christos Stefopoulos,Konstantinos Doudoumis,Georgios N. Theodorakis,Vassilios V. Voudris +7 more
TL;DR: Conduction was affected in all pts undergoing TAVI, but serious complications that required permanent pacing generally occurred in pts with pre-existing conduction abnormalities.
Journal ArticleDOI
Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial
Neeraj Badhey,Christopher Lichtenwalter,Christopher Lichtenwalter,James A. de Lemos,Michele Roesle,Owen Obel,Owen Obel,Tayo Addo,Donald Haagen,Abdul Rahman R Abdel-Karim,Abdul Rahman R Abdel-Karim,Bilal Saeed,Joe K. Bissett,Rajesh Sachdeva,Vassilios V. Voudris,Panagiotis Karyofillis,Biswajit Kar,James D. Rossen,Panayotis Fasseas,Peter B. Berger,Subhash Banerjee,Emmanouil S. Brilakis +21 more
TL;DR: EPDs were utilized in approximately half of SVG interventions in the SOS trial, yet availability of a proximal protection device could allow protection of ∼25% of unprotected lesions, yet operator discretion appears to be the major determinant of EPD use.